SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Scripts who wrote (839)3/14/2000 5:43:00 PM
From: Ian@SI  Read Replies (1) of 1321
 
I believe we have a major buying opportunity here; and not that POS, Procyon which hasn't a hope of ever having a blockbuster 1 / 100th as successful as Visudyne.

FDA ruling is expected within 4-6 weeks. From today's close, I'd expect a $30+ (US $) pop shortly thereafter. Not a bad return for a month's work.

It appears that we have John Majors to thank for this buying opportunity. I'd certainly agree that the Human Genome selloff was warranted and inevitable. But there were some 'babies' thrown out with the bath water. 'Babies' with real drugs in the pipeline and imminent, successful NDAs. QLT is one of those.

JMHO,
Ian.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News